FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 352:1731 April 21, 2005 Number 16 Next

PDF PDA Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Barnett, A. H.

Angiotensin-Receptor Blockade versus Converting–Enzyme Inhibition in Type 2 Diabetes and Nephropathy . On page 1952, in the Abstract, the first sentence of the Results section should have stated (with revised numbers in bold): "After five years, the change in the glomerular filtration rate was –17.5 ml per minute per 1.73 m² of body-surface area, where the minus sign denotes a decrement, with telmisartan (in 103 subjects), as compared with –15.0 ml per minute per 1.73 m² with enalapril (in 113 subjects), for a treatment difference of –2.6 ml per minute per 1.73 m² (95 percent confidence interval, –7.1 to 2.0 ml per minute per 1.73 m²)."

Also, on page 1957, in the left-hand column, lines 18 through 26 of the first full paragraph should have read (with revised numbers in bold): "After five years, the mean change in the glomerular filtration rate was –17.5 ml per minute per 1.73 m² (where the minus sign denotes a decrement) in the telmisartan-treated subjects, as compared with –15.0 ml per minute per 1.73 m² in the enalapril-treated subjects; the treatment difference was thus –2.6 ml per minute per 1.73 m² (95 percent confidence interval, –7.1 to 2.0 ml per minute per 1.73 m²)."

PDF PDA Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Barnett, A. H.

This article has been cited by other articles:

• Ravid, M. (2009). Dual Blockade of the Renin-Angiotensin System in Diabetic Nephropathy. Diabetes Care 32: S410-S413 [Full Text]